Intrapartum group B streptococcus (GBS) detection by intrapartum PCR versus antenatal culture at 35-38 weeks of gestation: Justification for a crossover, cluster randomized controlled trial, and protocol summary
Archives de Pédiatrie · 2026
DOI: 10.1016/j.arcped.2025.11.003 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives de Pédiatrie, 2026. Verfasst von Marine Godfroy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic and Obstetric Department, University Hospital of Angers, France. Hauptthemen laut MEDLINE: Neonatal Sepsis, Polymerase Chain Reaction, Pregnancy Complications, Infectious, Prenatal Diagnosis. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Ministry of Health & Wellness.
Abstract (Originalsprache)
The incidence of neonatal group B streptococcus (GBS) related to early onset sepsis (EOS) has decreased dramatically with antenatal culture screening and intrapartum antibiotic prophylaxis (IAP) implementation during the 1990s. However, while 30 % of women are currently exposed to intrapartum antibiotics, 52 to 82 % of newborns with GBS-EOS were born to mothers with negative antenatal GBS culture screening who did not receive IAP, because of possible intermittent maternal GBS colonization. Intrapartum GBS screening by Polymerase Chain Reaction (PCR) has been suggested as a suitable tool to improve and replace the usual antenatal GBS culture screening between 35 and 38 weeks of amenorrhea for optimizing the IAP indications, but its cost is often cited as an obstacle. Using a cluster crossover randomized controlled trial, we aim i) to conduct a cost-consequence analysis of two screening strategies and ii) to compare newborn and maternal morbi-mortality related to GBS-EOS and antibiotic exposure rate according to an intrapartum screening strategy versus usual antenatal culture screening (DEPIST2P study).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynecologic and Obstetric Department, University Hospital of Angers, France.
- Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France; INSERM CIC1415, CHRU de Tours, Tours, France.
- University Paris Est, AP-HP Health Economics Research Unit, Hôtel-Dieu Hospital, INSERM UMR 1153 CRESS, Paris, France.
- Nantes Université, CHU Nantes, INSERM, CIC 1413, F-44000 Nantes, France.
- University of Nantes, Research and Innovation Direction, CHU Nantes, F-44000 Nantes, France.
- Gynecologic and Obstetric Department, University Hospital of Angers, France; Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France; INSERM CIC1415, CHRU de Tours, Tours, France; University Paris…
Förderung
- Ministry of Health & Wellness
Zitieren
APA
Godfroy, M., Caille, A., Zaleski, I. D., Scherdel, P., Boivin, M., Benard, I., Chauvire-Drouard, A., Riche, V. P., Dochez, V., Winer, N., & Gras Le Guen, C. (2026). Intrapartum group B streptococcus (GBS) detection by intrapartum PCR versus antenatal culture at 35-38 weeks of gestation: Justification for a crossover, cluster randomized controlled trial, and protocol summary. Archives de Pédiatrie. https://doi.org/10.1016/j.arcped.2025.11.003
Vancouver
Godfroy M, Caille A, Zaleski ID, Scherdel P, Boivin M, Benard I, et al. Intrapartum group B streptococcus (GBS) detection by intrapartum PCR versus antenatal culture at 35-38 weeks of gestation: Justification for a crossover, cluster randomized controlled trial, and protocol summary. Archives de Pédiatrie. 2026. doi:10.1016/j.arcped.2025.11.003
BibTeX
@article{Godfroy2026,
author = {Godfroy, Marine and Caille, Agnès and Zaleski, Isabelle Durand and Scherdel, Pauline and Boivin, Marion and Benard, Ingrid and Chauvire-Drouard, Anne and Riche, Valery-Pierre and Dochez, Vincent and Winer, Norbert and Gras Le Guen, Christèle},
title = {Intrapartum group B streptococcus (GBS) detection by intrapartum PCR versus antenatal culture at 35-38 weeks of gestation: Justification for a crossover, cluster randomized controlled trial, and protocol summary},
journal = {Archives de Pédiatrie},
year = {2026},
doi = {10.1016/j.arcped.2025.11.003}
}
EUVIMED